IBB vs SPYD
iShares Biotechnology ETF vs SPDR Portfolio S&P 500 High Dividend ETF
- • SPYD has the lower expense ratio at 0.07% vs 0.44% for IBB.
- • SPYD pays a higher dividend yield (4.20%).
Side-by-side metrics
| Metric | IBB | SPYD |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.07% |
Dividend yield Trailing 12-month yield. | 0.16% | 4.20% |
AUM Assets under management — bigger funds are typically more liquid. | $11.50B | $7.64B |
YTD return | 30.22% | 19.42% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.60 | 0.55 |
P/E ratio | 25.48 | 15.99 |
Last price | $217.75 | $49.87 |
Inception | — | — |
Issuer | iShares | State Street |
IBB top holdings
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
SPYD top holdings
| ACN | Accenture PLC Class A | 2.35% |
| HAS | Hasbro Inc | 1.71% |
| PFE | Pfizer Inc | 1.57% |
| CVX | Chevron Corp | 1.56% |
| MDT | Medtronic PLC | 1.51% |
| SWK | Stanley Black & Decker Inc | 1.48% |
| EOG | EOG Resources Inc | 1.47% |
| HPQ | HP Inc | 1.46% |
| CCI | Crown Castle Inc | 1.46% |
| AMT | American Tower Corp | 1.44% |
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About SPYD
SPYD (SPDR Portfolio S&P 500 High Dividend ETF) is Top 80 highest-yielding S&P 500 stocks. Managed by State Street, the fund carries $7.6B in assets under management, an expense ratio of 0.07%, a dividend yield of 4.20%. Its largest holding is Accenture PLC Class A (ACN), which represents 2.4% of the portfolio. Real Estate is the fund's largest sector exposure at 24.2%.